Home › Funds › Linscomb Wealth, Inc. › JNJ

Linscomb Wealth, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Linscomb Wealth, Inc. reported holding 58,138 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 0.67% of its reported portfolio and ranking #25 among its reported holdings. Linscomb Wealth, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)58.14K sh
Reported value held$15.39M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Linscomb Wealth, Inc.'s JNJ position evolved

Linscomb Wealth, Inc. first disclosed a stake in JNJ in Q3 2023 at 70,795 shares (US$11.0M). The position peaked in Q1 2026 at 74,211 shares, worth US$18.1M. Across 13 filings, Linscomb Wealth, Inc. increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 58,138 shares valued at US$15.4M — a reduction of -1,330 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 70.80K $11.03M New
Q4 2023 70.15K $11.00M Reduce
Q1 2024 68.95K $10.91M Reduce
Q2 2024 69.67K $10.18M Add
Q3 2024 69.01K $11.18M Reduce
Q4 2024 69.83K $10.10M Add
Q1 2025 72.80K $12.07M Add
Q2 2025 75.60K $11.55M Add
Q3 2025 76.60K $14.20M Add
Q4 2025 77.63K $16.07M Add
Q1 2026 74.21K $18.14M Reduce
Q2 2026 59.47K $15.10M Reduce
Q3 2026 58.14K $15.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Linscomb Wealth, Inc. held JNJ?

Linscomb Wealth, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Linscomb Wealth, Inc.'s current position in JNJ?

As of Q3 2026, Linscomb Wealth, Inc. holds 58.14K shares of JNJ (JOHNSON & JOHNSON), valued at $15.39M, representing 0.67% of its reported portfolio and ranking #25.

Has Linscomb Wealth, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Linscomb Wealth, Inc. reduced its position in JNJ. The position peaked in Q1 2026 at 74.21K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.